Bispecific antibodies: raising new horizons for RRMM?

Learning objective:

After participating in this webinar, viewers should be able to:

• Discuss the latest data relating to the use of bispecifics in the management of patients with RRMM  

Faculty:

• María Victoria Mateos (Spain)
• Niels van de Donk (Netherlands)
• Ajai Chari (USA)